| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/2009 | US20090143324 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/04/2009 | US20090143323 Double-stranded ribonucleic acid havng a sense strand and an antisense strand with specific sequences; mediating RNA interference; decreasing virus titre and sustaining platelet count and lymphocyte count |
| 06/04/2009 | US20090143321 Nucleic acid agents for downregulating h19 and methods of using same |
| 06/04/2009 | US20090143320 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143318 Degranulation inhibitor |
| 06/04/2009 | US20090143317 Quercetin Glycoside Composition and Method of Preparing the Same |
| 06/04/2009 | US20090143316 Cocrystal of c-glycoside derivative and l-proline |
| 06/04/2009 | US20090143315 Salix extract, its use and formulations containing it |
| 06/04/2009 | US20090143314 Compositions and methods for combination antiviral therapy |
| 06/04/2009 | US20090143313 Treatment or Prevention of Hemorrhagic Viral Infections with Immunomodulator Compounds |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143307 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143306 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143305 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143304 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143302 Pyrimidine compounds |
| 06/04/2009 | US20090143295 Peptide-based antiacne reagents |
| 06/04/2009 | US20090143294 Administering a sub-constricting amount of calyculin A and a vasoconstrictor where the sub-constricting amount is sufficient to restore blood vessel sensitivity to the vasoconstrictor and does not cause contraction of the blood vessel itself; antishock agents; a myosin light chain phosphatase inhibitor |
| 06/04/2009 | US20090143290 Tumor-inhibiting protein and the use thereof |
| 06/04/2009 | US20090143289 Orthopoxvirus vectors, genes and products thereof |
| 06/04/2009 | US20090143282 Enhanced recovery following ocular surgery |
| 06/04/2009 | US20090143280 Anti-cancer combination treatment and kit-of-parts |
| 06/04/2009 | US20090143279 Methods and compositions for treating metabolic disorders |
| 06/04/2009 | US20090143277 Nutritional composition for controlling blood sugar level |
| 06/04/2009 | US20090142850 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142427 Composition and its Therapeutic Use |
| 06/04/2009 | US20090142425 Physiologically active composition |
| 06/04/2009 | US20090142421 Active fraction of a polar solvent extract from the latex of euphorbiaceae plants |
| 06/04/2009 | US20090142420 Cosmetic Composition with Anti-Free Radical Activity |
| 06/04/2009 | US20090142413 Targeted short-lived drug delivery |
| 06/04/2009 | US20090142412 Skin Care Cosmetic Cream/Scrub Product |
| 06/04/2009 | US20090142404 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 06/04/2009 | US20090142403 Organ regeneration device |
| 06/04/2009 | US20090142400 Analgesic coated medical product |
| 06/04/2009 | US20090142398 Novel pharmaceutical compositions comprising a disintegration matrix |
| 06/04/2009 | US20090142397 Reduction of dermal scarring |
| 06/04/2009 | US20090142395 Deferasirox pharmaceutical compositions |
| 06/04/2009 | US20090142393 Stable Compositions of Famotidine and Ibuprofen |
| 06/04/2009 | US20090142392 Composition Comprising a NSAID and Paracetamol |
| 06/04/2009 | US20090142391 Conjugated RNAi Therapeutics |
| 06/04/2009 | US20090142390 Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
| 06/04/2009 | US20090142378 Controlled release dosage forms |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142355 Diagnosis and treatment of type 1 diabetes |
| 06/04/2009 | US20090142347 Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification |
| 06/04/2009 | US20090142344 Breast cancer related gene znfn3a1 |
| 06/04/2009 | US20090142337 Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment |
| 06/04/2009 | US20090142336 Metabolic regulators and uses thereof |
| 06/04/2009 | US20090142335 Methods of diagnosis and treatment of metabolic disorders |
| 06/04/2009 | US20090142334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE |
| 06/04/2009 | US20090142332 Identification of Biomarkers by Serum Protein Profiling |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142324 Oil-in-water type emulsion containing coenzyme q10 and process for producing the same |
| 06/04/2009 | US20090142323 Methods for treating a disorder by regulating gprc6a |
| 06/04/2009 | US20090142321 Opthalmic composition |
| 06/04/2009 | US20090142316 Use of Dendrimers to Stimulate Cell Growth |
| 06/04/2009 | US20090142314 Maternal supplement |
| 06/04/2009 | US20090142313 Vaginal delivery system |
| 06/04/2009 | US20090142310 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 06/04/2009 | US20090142309 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 06/04/2009 | US20090142304 Composition for Improving Intestinal Flora |
| 06/04/2009 | US20090142302 Insulin-like growth factor binding protein 7 for treatment of cancer |
| 06/04/2009 | US20090142301 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 06/04/2009 | US20090142300 Compositions and methods related to toll-like receptor-3 |
| 06/04/2009 | US20090142297 5-substituted isoindoline compounds |
| 06/04/2009 | US20090142295 Anti-Connexin Compounds and Uses Thereof |
| 06/04/2009 | US20090142292 Method For The Mitigation of Symptoms of Dry Eye |
| 06/04/2009 | US20090142291 Pigmented cosmetic and personal care composition and process for preparing the same |
| 06/04/2009 | US20090142279 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/04/2009 | US20090142278 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto |
| 06/04/2009 | US20090142269 Isotoypically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| 06/04/2009 | US20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 06/04/2009 | DE19549852B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/04/2009 | DE10315878B4 Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung The transdermal administration of fesoterodine and use |
| 06/04/2009 | DE102007058220A1 New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors |
| 06/04/2009 | CA2802984A1 Use of eph-b4 and ephrin-a1 for predicting negative physiological response to the treatment with erythropoietin |
| 06/04/2009 | CA2744736A1 Compositions comprising nicotinic agonists and methods of using same |
| 06/04/2009 | CA2707424A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 06/04/2009 | CA2707174A1 Benzomorphan compounds |
| 06/04/2009 | CA2707161A1 Compositions and methods for inhibiting cytochrome p450 2d6 |
| 06/04/2009 | CA2707153A1 Cancer treatment using cox-2 inhibitor and antimetabolite combinations |
| 06/04/2009 | CA2707117A1 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders |
| 06/04/2009 | CA2707107A1 Therapeutic targets and medicaments involving p230/golgin-245 |
| 06/04/2009 | CA2707095A1 Phenyl-oxetanyl-derivatives |
| 06/04/2009 | CA2707089A1 Mcp-1 binding nucleic acids and use thereof |
| 06/04/2009 | CA2707009A1 Methods for inhibiting fascin |
| 06/04/2009 | CA2707001A1 Smokeless compressed tobacco product for oral consumption |
| 06/04/2009 | CA2706986A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | CA2706974A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/04/2009 | CA2706973A1 Alginate biomaterials for the treatment of hepatic disorders |
| 06/04/2009 | CA2706946A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| 06/04/2009 | CA2706929A1 Novel naphthyridine derivative monohydrate and method for producing the same |
| 06/04/2009 | CA2706866A1 Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | CA2706775A1 Crystal forms of o-desmethylvenlafaxine fumarate |
| 06/04/2009 | CA2706768A1 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| 06/04/2009 | CA2706750A1 Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
| 06/04/2009 | CA2706746A1 Cysteine protease inhibitors for the treatment of parasitic diseases |